Working… Menu
Trial record 1 of 1 for:    NCT04713553
Previous Study | Return to List | Next Study

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04713553
Recruitment Status : Recruiting
First Posted : January 19, 2021
Last Update Posted : June 11, 2021
Information provided by (Responsible Party):
BioNTech SE

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 22, 2021
Estimated Study Completion Date : July 22, 2021